Hanker LC, FOrster F, SchrOder J, Grafe A, et al. Resumption of Trastuzumab in Patients With Disease Recurrence After (Neo-) Adjuvant Anti-HER2-therapy in Patients With HER2-positive Breast Cancer. Anticancer Res 2020;40:3973-3981.
PMID: 32620640